Improving medication adherence with orally disintegrating tablets

Nursing

Volumn 36, Issue 9, 2006, Pages 20-21

  Uko Ekpenyong, Grace ^a  

^a Department of Microbiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; CASE REPORT; CHEMISTRY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOSIS; TABLET;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOTIC DISORDERS; RISPERIDONE; TABLETS;

EID: 33748299609     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/00152193-200609000-00012     Document Type: Review

References (4)

1. Marland GR, Cash K. Medicine taking decisions: Schizophrenia in comparison to asthma and epilepsy. Journal of Psythiatric and Mental Health Nursing. 12(2): 163-172, April 2005.
2. Nursing2007 Drug Handbook. Pliiladelphia, Pa., Lippincott Williams & Wilkins, 2007.
3. Risperdal. http://www.risperdal.com. Accessed July 20. 2006.
4. Zygmunt A, et al. Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry. 159(10): 1653-1664, October 2002.